The CXCR4 chemokine receptor plays a pivotal role in regulating immune cell migration, hematopoiesis, and metastasis in various cancers. As a result, selective inhibitors of the CXCR4 receptor have emerged as a promising therapeutic approach for treating cancer, hematological disorders, and inflammatory diseases. CXCR4 inhibitors are being developed to block this receptor’s...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian